20 Hrs
المصدر:
Financial Times
QuidelOrtho considers selling testing division
Shares of the diagnostic company have declined by 90% since its rapid antigen tests became the first to receive approval for Covid-19 testing.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading